0469-0125Level 3
Xtandi (enzalutamide)
**Product type:** Human Prescription Drug
**Active ingredient:** ENZALUTAMIDE
**Strength:** 40 mg/1
**Dosage form:** Capsule
**Route:** Oral
**Labeler:** Astellas Pharma US, Inc.
**Marketing category:** NDA (NDA203415)
**Pharmacologic class:** Androgen Receptor Antagonists [MoA], Androgen Receptor Inhibitor [EPC], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA]
GET
/api/v1/systems/ndc_fda/nodes/0469-0125Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.